We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LKFT
2976
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.92B
| $219K | ﹤0.01% |
7,297
-84
| -1% | -$2.38K |
|
2977
Lyell Immunopharma
LYEL
$241M
| $217K | ﹤0.01% |
+15,462
| New | +$280K |
|
2978
E.W. Scripps
SSP
$256M
| $217K | ﹤0.01% |
78,187
-34
| -0% | -$129 |
|
2979
OR Royalties Inc
OR
$6.7B
| $216K | ﹤0.01% |
6,841
-105
| -2% | -$3.88K |
|
2980
Brookfield
BN
$82.3B
| $216K | ﹤0.01% |
5,073
-301
| -6% | -$13.5K |
|
2981
Medallion Financial
MFIN
$275M
| $215K | ﹤0.01% |
21,097
-827
| -4% | -$7.82K |
|
|
COSO
2982
CoastalSouth Bancshares
COSO
$318M
| $215K | ﹤0.01% |
8,018
+2,667
| +50% | +$68.9K |
|
|
CMDB
2983
Costamare Bulkers Holdings
CMDB
$532M
| $215K | ﹤0.01% |
12,256
+240
| +2% | +$4.17K |
|
2984
Advantage Solutions
ADV
$425M
| $215K | ﹤0.01% |
4,962
+404
| +9% | +$14.3K |
|
2985
Arcturus Therapeutics
ARCT
$394M
| $214K | ﹤0.01% |
31,887
+1,011
| +3% | +$7.97K |
|
2986
SEACOR Marine Holdings
SMHI
$237M
| $213K | ﹤0.01% |
27,806
-866
| -3% | -$6.43K |
|
|
ISBA
2987
Isabella Bank
ISBA
$293M
| $212K | ﹤0.01% |
+5,355
| New | +$229K |
|
|
IRD
2988
Opus Genetics
IRD
$396M
| $212K | ﹤0.01% |
+51,464
| New | +$240K |
|
|
MDV
2989
DELISTED
Modiv Industrial
MDV
| $211K | ﹤0.01% |
12,133
+159
| +1% | +$2.73K |
|
2990
Surrozen
SRZN
$347M
| $211K | ﹤0.01% |
+8,130
| New | +$223K |
|
2991
FirstService
FSV
$5.62B
| $209K | ﹤0.01% |
1,472
-113
| -7% | -$15.7K |
|
2992
Citizens
CIA
$182M
| $209K | ﹤0.01% |
36,420
+3,927
| +12% | +$21.3K |
|
2993
Acacia Research
ACTG
$417M
| $208K | ﹤0.01% |
44,731
+390
| +0.9% | +$1.87K |
|
2994
Organogenesis Holdings
ORGO
$181M
| $208K | ﹤0.01% |
85,660
+5,645
| +7% | +$13.8K |
|
|
PPIH
2995
Perma-Pipe International
PPIH
$260M
| $204K | ﹤0.01% |
+7,497
| New | +$231K |
|
2996
ECB Bancorp
ECBK
$181M
| $204K | ﹤0.01% |
10,154
+370
| +4% | +$6.84K |
|
2997
Manulife Financial
MFC
$72.7B
| $204K | ﹤0.01% |
5,030
-293
| -6% | -$11.3K |
|
2998
Voyager Therapeutics
VYGR
$165M
| $204K | ﹤0.01% |
58,174
+608
| +1% | +$2.31K |
|
2999
BV Financial
BVFL
$177M
| $204K | ﹤0.01% |
9,611
-573
| -6% | -$11.4K |
|
3000
First United
FUNC
$279M
| $202K | ﹤0.01% |
4,587
+101
| +2% | +$3.94K |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.